Position
Quantbot Technologies LP in Kymera Therapeutics, Inc.
Back to the book · All holders of KYMR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $263$77.81 → $83.29
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 48 | $3.73K | — | — | — | 0.0% |
| Q1 2026 | 1.8K | $149.8K | $83.29 | $263 | $145.8K | 0.0% |